The application of single-cell RNA sequencing in COVID-19 research has greatly improved our understanding of COVID-19 pathogenesis and immunological characteristics. In this commentary, researchers from the University of Texas Health Science Center at Houston discuss the current challenges, limitations, and perspectives in harnessing the power of single-cell RNA sequencing to accelerate both basic research and therapeutic development for COVID-19 and other emerging infectious diseases.
Liu W, Ye X, An Z, Zhao Z. (2022) The challenges and opportunities of scRNA-seq in COVID-19 research and clinical translation. Virol J 19(1):217. [article]
